Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Crystal structures of P450s
- Structures of P450s
- CYPs 3A4, 2A6 and 101
- CYP2C5/diclofenac complex
- Targeting of P450s to membranes
- Microsomal P450s for crystall.
- P450-membrane interactions
- Proximal face of P450 2C5
- Role of heme in O2 reduction
- P450 heme binding site: CYP101 (1)
- P450 heme binding site: CYP101 (2)
- Substrate binding in CYP2C5
- Family 2 P450s
- P450s 2C8, 2C5 and 2A6
- Comparison of CYP2C8/CYP2C5
- Active site cavities - size/shape diff.
- Active site shape and volume
- Size discrimination
- CYP2C5 - DFC vs. DMZ binding
- DMZ/DFC complexes of CYP2C5
- CYP2B4 - open/closed confo. (1)
- CYP2B4 - open/closed confo. (2)
- P450 flexibility
- CYP2A6
- Coumarin bound to CYP2A6
- Substrate binding to P450s
- CYP2C9 substrates
- WT/mutant CYP2C9 conformations
- CYP2C9 complexes - 1OG5/1R9O
- Flurbiprofen contacts in CYP2C9
- S-warfarin binding to CYP2C9
- Small substrates - large active sites
- Flurbiprofen complex of CYP2C9
- CYP3A4 substrates
- Structures of CYP 3A4 and 2C8
- In silico docking of testosterone
- CYP3A4 structures
- Metyrapone bound to CYP3A4
- Interfaces of CYP 2C8 and 3A4
- CYP2C8 substrates
- Montelukast bound to CYP2C8
- Summary
Topics Covered
- Introduction to CYP450 architecture
- Shared structural features
- Catalytic mechanism
- Redox partner interactions
- Membrane topology
- Multiple modes of substrate binding and oxidation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Johnson, E. (2007, October 1). Crystal structures of drug-metabolizing P450 monooxygenases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/IRAM9877.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Eric Johnson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.